Statistics
Publications
1
Citations
117
H-Index
1
Active since
2013
Affiliations
Palmetto Hematology Oncology(Current)
Ziehr is an author at Palmetto Hematology Oncology specializing in targeted cancer therapy, epidermal growth factor receptor inhibition, and activating mutations.
Publications per year
2013–2013
1
1
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC
Mark Agulnik, Ziehr, J R Johnson · OncoTargets and Therapy · 2013 · 117 citations · Full text
Medicine, Oncology, Pharmacology +15
1–1 of 1